Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Elevated Pretransplantation Soluble BAFF Is Associated With an Increased Risk of Acute Antibody-Mediated Rejection
Authors
Keywords
-
Journal
TRANSPLANTATION
Volume 96, Issue 4, Pages 413-420
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2013-07-09
DOI
10.1097/tp.0b013e318298dd65
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- BAFF and BAFF-R Levels Are Associated With Risk of Long-Term Kidney Graft Dysfunction and Development of Donor-Specific Antibodies
- (2012) A. Thibault-Espitia et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Murine Islet Allograft Tolerance Upon Blockade of the B-Lymphocyte Stimulator, BLyS/BAFF
- (2012) Ronald F. Parsons et al. TRANSPLANTATION
- Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial
- (2012) Ellen M Ginzler et al. ARTHRITIS RESEARCH & THERAPY
- Targeting B Cells and Antibody in Transplantation
- (2011) M. R. Clatworthy AMERICAN JOURNAL OF TRANSPLANTATION
- Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial
- (2011) Sandra V Navarra et al. LANCET
- Increased levels of BAFF in patients with systemic lupus erythematosus are associated with acute-phase reactants, independent of BAFF genetics: a case–control study
- (2011) Gro Ø. Eilertsen et al. RHEUMATOLOGY
- Human Leukocyte Antigen Antibody-Incompatible Renal Transplantation: Excellent Medium-Term Outcomes With Negative Cytotoxic Crossmatch
- (2011) Robert Higgins et al. TRANSPLANTATION
- B cells and transplantation tolerance
- (2010) Allan D. Kirk et al. Nature Reviews Nephrology
- BAFF Is Increased in Renal Transplant Patients Following Treatment with Alemtuzumab
- (2009) D. Bloom et al. AMERICAN JOURNAL OF TRANSPLANTATION
- B-Cell Reconstitution and BAFF After Alemtuzumab (Campath-1H) Treatment of Multiple Sclerosis
- (2009) Sara A. J. Thompson et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression
- (2009) M. V. Pahl et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- B Cell Survival in Intragraft Tertiary Lymphoid Organs After Rituximab Therapy
- (2009) Olivier Thaunat et al. TRANSPLANTATION
- BAFF May Modulate the Rate of B-Cell Repopulation After Rituximab Therapy for Acute Renal Transplant Rejection
- (2009) Valeriya Zarkhin et al. TRANSPLANTATION
- The Expression of B-Cell Activating Factor Belonging to Tumor Necrosis Factor Superfamily (BAFF) Significantly Correlated With C4D in Kidney Allograft Rejection
- (2009) H. Xu et al. TRANSPLANTATION PROCEEDINGS
- Abnormal High Expression of B-Cell Activating Factor Belonging to the TNF Superfamily (BAFF) Associated With Long-Term Outcome in Kidney Transplant Recipients
- (2009) H. Xu et al. TRANSPLANTATION PROCEEDINGS
- Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort
- (2009) Jacques-Eric Gottenberg et al. ARTHRITIS RESEARCH & THERAPY
- APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells
- (2008) E. Belnoue et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now